Response to Letter to the Editor: "Higher Circulating Adiponectin Concentrations Predict Incident Cancer in Type 2 Diabetes - The Adiponectin Paradox"
J Clin Endocrinol Metab
.
2020 Sep 1;105(9):dgaa386.
doi: 10.1210/clinem/dgaa386.
Authors
Chi Ho Lee
1
2
3
,
David T W Lui
1
,
Chloe Y Y Cheung
1
,
Carol H Y Fong
1
,
Michele M A Yuen
1
,
Wing Sun Chow
1
,
Yu Cho Woo
1
,
Aimin Xu
1
2
3
,
Karen S L Lam
1
2
3
Affiliations
1
Department of Medicine, University of Hong Kong, Hong Kong SAR.
2
Research Center of Heart, Brain, Hormone and Healthy Aging, University of Hong Kong, Hong Kong SAR.
3
State Key Laboratory of Pharmaceutical Biotechnology, University of Hong Kong, Hong Kong SAR.
PMID:
32589739
DOI:
10.1210/clinem/dgaa386
No abstract available
Publication types
Letter
Comment
MeSH terms
Adiponectin
Diabetes Mellitus, Type 2* / epidemiology
Humans
Neoplasms* / epidemiology
Risk Factors
Substances
Adiponectin